Keywords: فسفودی استراز نوع 5; testicular neoplasms; erectile dysfunction; radiotherapy; drug therapy; survivors; BEP; bleomycin, etoposide and cisplatin; DaTeCa; Danish Testicular Cancer; HADS; Hospital Anxiety and Depression Scale; IIEF-15; International Index of Erectile Function-15
مقالات ISI فسفودی استراز نوع 5 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فسفودی استراز نوع 5; Melanoma; Basal Cell Carcinoma; Squamous Cell Carcinoma; Phosphodiesterase Type 5; Erectile Dysfunction; Lower Urinary Tract Symptoms; Pulmonary Hypertension;
Keywords: فسفودی استراز نوع 5; Tadalafil; Pulmonary hypertension; Phosphodiesterase type 5; Vascular remodeling; Pulmonary artery; Smooth muscle;
Keywords: فسفودی استراز نوع 5; PDE5; phosphodiesterase type 5; BDNF; brain derived neurotrophic factor; NE; norepinephrine; 5-HIAA; 5-hydroxyindoleacetic acid; ROS; reactive oxygen species; Noise; Sildenafil; Phosphodiesterase type 5 inhibitors; Oxidative stress; Cognition; Behavior; M
Keywords: فسفودی استراز نوع 5; Erectile Dysfunction; Radical Prostatectomy; Cavernous Nerve Injury; Cell Therapy; Corpus Cavernosum; Endothelium-Dependent Relaxation; Nitrergic Relaxation; Phosphodiesterase Type 5
Keywords: فسفودی استراز نوع 5; Pulmonary arterial hypertension; Right ventricular failure; Pathophysiological mechanisms; Pulmonary arterial hypertension experimental models; Hypertension artérielle pulmonaire (HTAP); Insuffisance ventriculaire droite; Mécanismes physiopathologiques
Keywords: فسفودی استراز نوع 5; Erection; Erectile dysfunction; Nitric oxide; Phosphodiesterase type 5
Keywords: فسفودی استراز نوع 5; AA; arachidonic acid; NSAID; non-steroidal anti-inflammatory drug; FAP; familial adenomatous polyposis; TA; tolfenamic acid; SS; sulindac sulfide; EGR-1; early growth response-1; NAG-1; NSAID-activated gene-1; EMT; epithelial-mesenchymal transition; bZIP;
Effect of BKCa Channel Opener LDD175 on Erectile Function in an In Vivo Diabetic Rat Model
Keywords: فسفودی استراز نوع 5; Erectile Dysfunction; BK Channel; LDD175; Phosphodiesterase Type 5;
Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation
Keywords: فسفودی استراز نوع 5; AE; adverse event; AI; augmentation index; AUC; area under the curve; BID; twice daily; Cavg; average concentration; Cmax; maximal concentration; mg; milligrams; mL; milliliters; MPI; myocardial performance index; ng; nanograms; PAT; peripheral arterial t
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis
Keywords: فسفودی استراز نوع 5; ACE2; angiotensin I converting enzyme 2; AGT; angiotensinogen; ATI; alveolar epithelial cells type I; ATII; alveolar epithelial cells type II; BALF; bronchial alveolar lavage fluid; BMP2; bone morphogenetic protein 2; BMPR1A; bone morphogenetic protein re
l-Cys/CSE/H2S pathway modulates mouse uterus motility and sildenafil effect
Keywords: فسفودی استراز نوع 5; Sildenafil; l-Cysteine; Sodium hydrogen sulfide; PDE5; phosphodiesterase type 5; H2S; hydrogen sulfide; l-Cys; l-Cysteine; CBS; cystathionine-β-synthase; CSE; cystathionine-γ-lyase; PAG; DL-propargilglycine; AOAA; aminooxiacetic acid; Emax; maximum effe
S-nitrosylation of PDE5 increases its ubiquitin-proteasomal degradation
Keywords: فسفودی استراز نوع 5; cGMP; cyclic guanosine monophosphate; DETA-NO; diethylenetriamine NONOate; GSNO; S-nitrosoglutathione; KT5823; 2,3,9,10,11,12-hexahydro-10R-methoxy-2,9-dimethyl-1-oxo-9S,12R-epoxy-1H-diindolo[1,2,3-fg:3â²,2â²,1â²-kl]pyrrolo[3][1,6]benzodiazocine-10-car
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: فسفودی استراز نوع 5; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Vaginal Lubrication after Cervicovaginal Stimulation Is Facilitated by Phosphodiesterase Type 5 Inhibition in Ovariectomized Mice
Keywords: فسفودی استراز نوع 5; Vagina; Lubrication; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase Type 5; Estrogens;
The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
Keywords: فسفودی استراز نوع 5; Benign prostatic hyperplasia; Lower urinary tract symptoms; Phosphodiesterase type 5; Phosphodiesterase type 5 inhibitors; Mechanism of action
Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice
Keywords: فسفودی استراز نوع 5; HPLC; high-performance liquid chromatography; PDE5; phosphodiesterase type 5; NO; nitric oxide; GC; guanylate cyclase; cGMP; guanosine 3´,5´-monophosphate; GABA; γ-aminobutyric acid; NMDA; N-methyl-d-aspartate; SERT; serotonin transporter; Antidepressa
Immunohistochemical and functional characterization of nitric oxide signaling pathway in isolated aorta from Crotalus durissus terrificus
Keywords: فسفودی استراز نوع 5; Aorta; Crotalus durissus; Nitric oxide synthase; Phosphodiesterase type 5; Soluble guanylyl cyclase;
Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: Indications for central and peripheral mechanisms
Keywords: فسفودی استراز نوع 5; Phosphodiesterase type 5; cGMP; Vardenafil; UK-343,664; Object recognition; Memory; Central and peripheral mechanisms;
The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
Keywords: فسفودی استراز نوع 5; ABI; ankle-brachial index; ACCF; American College of Cardiology Foundation; AHA; American Heart Association; BMI; body mass index; BP; blood pressure; CACS; coronary artery calcium scoring; CAD; coronary artery disease; CCTA; coronary computed tomographic
Sinusoidal electromagnetic field stimulates rat osteoblast differentiation and maturation via activation of NO-cGMP-PKG pathway
Keywords: فسفودی استراز نوع 5; NOS; nitric oxide synthase; NO; nitric oxide; ALP; alkaline phosphatase; SEMF; sinusoidal electromagnetic field; ROB; rat osteoblast; OSX; osterix; PBS; phosphate buffered saline; a-MEM; a-minimal essential medium; FBS; fetal bovine serum; ROD; relative o
Protective effects of tadalafil on experimental spinal cord injury in rats
Keywords: فسفودی استراز نوع 5; Antioxidant; Glutathione peroxidase; Malondialdehyde; Nitric oxide; Oxidant; Phosphodiesterase type 5; Spinal cord injury, Spine; Superoxide dismutase; Tadalafil
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: فسفودی استراز نوع 5; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Ginsenoside Rg1 Improves Male Copulatory Behavior Via Nitric Oxide/Cyclic Guanosine Monophosphate Pathway
Keywords: فسفودی استراز نوع 5; Ginsenoside Rg1; Male Copulatory Behavior; Sexual Function in Aging Men; Nitric Oxide; Phosphodiesterase Type 5; Cyclic Guanosine Monophosphate;
Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
Keywords: فسفودی استراز نوع 5; Phosphodiesterase type 5; Lower Urinary Tract; Human Smooth Muscle Cell Proliferation; Lower Urinary Tract Symptoms;
Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions
Keywords: فسفودی استراز نوع 5; BPH; benign prostatic hyperplasia; CAD; coronary artery disease; CI; confidence interval; CVD; cardiovascular disease; ED; erectile dysfunction; EF; ejection fraction; HbA1c; hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; IIEF; International
Aspects of Sexual Satisfaction in Men with Erectile Dysfunction: A Factor Analytic and Logistic Regression Approach
Keywords: فسفودی استراز نوع 5; Drug Therapy; Erectile Dysfunction; Phosphodiesterase Type 5; Satisfaction; Treatment Outcome;
Effect of Vardenafil on Blood Pressure Profile of Patients With Erectile Dysfunction Concomitantly Treated With Doxazosin Gastrointestinal Therapeutic System for Benign Prostatic Hyperplasia
Keywords: فسفودی استراز نوع 5; adrenergic alpha-antagonists; phosphodiesterase inhibitors; prostatic hyperplasia; erectile dysfunction; α1-AR blocker; α1-adrenergic receptor blocker; BP; blood pressure; BPH; benign prostatic hyperplasia; DBP; diastolic blood pressure; ED; erectile dy
Safety of Prescribing PDE-5 Inhibitors via e-Medicine vs Traditional Medicine
Keywords: فسفودی استراز نوع 5; CI; confidence interval; IIEQ; International Index of Erectile Questions; PDE-5; phosphodiesterase type 5; RR; relative risk;
Nocturnal Tumescence: A Parameter for Postoperative Erectile Integrity After Nerve Sparing Radical Prostatectomy
Keywords: فسفودی استراز نوع 5; impotence; prostatectomy; prostatic neoplasms; penile erection; ED; erectile dysfunction; IIEF; International Index of Erectile Function; NPTR; nocturnal penile tumescence and rigidity; PDE5; phosphodiesterase type 5; RP; radical prostatectomy;
AntidepressantâInduced Inhibition of Genital Vascular Responses Is Reversed by Vardenafil in Female Rabbits
Keywords: فسفودی استراز نوع 5; Antidepressant; Female Sexual Dysfunction; Genital Vascular Responses; Nitric Oxide; Vardenafil; Phosphodiesterase Type 5; Paroxetine; Venlafaxine; Duloxetine;
Sustained Efficacy and Safety of Vardenafil for Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study
Keywords: فسفودی استراز نوع 5; AE; adverse event; ANCOVA; analysis of covariance; ED; erectile dysfunction; EF; erectile function; GAQ; Global Assessment Question; IIEF; International Index of Erectile Function; ITT; intent-to-treat; LS; least squares; LOCF; last observation carried fo
An Evaluation of an Alternative Dosing Regimen with Tadalafil, 3 Times/Week, for Men with Erectile Dysfunction: SURE Study in 14 European Countries
Keywords: فسفودی استراز نوع 5; ED; erectile dysfunction; EF; erectile function; IIEF; International Index of Erectile Function; PDE5; phosphodiesterase type 5; SEP; Sexual Encounter Profile; TEAE; treatment-emergent adverse events; TPQ; Treatment Preference Question; SURE; Scheduled Us
Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk
Keywords: فسفودی استراز نوع 5; Phosphodiesterase type 5; Endothelial dysfunction; Erectile dysfunction; Rehabilitation; Arterial dilatation;